Vol. 79 No. 3-4 (2013): Pulmonary series - Supplement 1
Editorial
-
Roflumilast: the fourth Mousquetaire in COPD pharmacological treatment
DOI https://doi.org/10.4081/monaldi.2013.26
- 1,643 abstract views
- 829 PDF
Reviews
-
The use of roflumilast in COPD: a review
DOI https://doi.org/10.4081/monaldi.2013.27
- 1,767 abstract views
- 884 PDF
Case Reports
-
Roflumilast is safe and effective in improving symptoms and lung function in severe COPD
DOI https://doi.org/10.4081/monaldi.2013.28
- 1,874 abstract views
- 917 PDF
-
Two cases of COPD benefitting from therapy with roflumilast
DOI https://doi.org/10.4081/monaldi.2013.29
- 1,552 abstract views
- 922 PDF
-
Roflumilast succeeds where traditional therapy fails: a case report
DOI https://doi.org/10.4081/monaldi.2013.30
- 1,410 abstract views
- 829 PDF
-
Roflumilast is effective in reducing COPD related exacerbations and improving CAT score
DOI https://doi.org/10.4081/monaldi.2013.32
- 1,565 abstract views
- 821 PDF
-
Significant gas-exchange improvements reported after roflumilast in two cases of severe COPD
DOI https://doi.org/10.4081/monaldi.2013.33
- 1,341 abstract views
- 889 PDF